Prevalence of unrecognized abnormal glucose tolerance in patients attending a hospital hypertension clinic

Diabetes mellitus (DM) and impaired glucose tolerance (IGT) are not uncommonly associated with hypertension. Fasting blood glucose level is still recognized as an indicator of DM. We studied 99 consecutive patients who were not known to be diabetic patients and with no cardiac history, who were atte...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of hypertension 2004-06, Vol.17 (6), p.483-488
Hauptverfasser: Salmasi, Abdul-Majeed, Alimo, Audrey, Dancy, Mark
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 488
container_issue 6
container_start_page 483
container_title American journal of hypertension
container_volume 17
creator Salmasi, Abdul-Majeed
Alimo, Audrey
Dancy, Mark
description Diabetes mellitus (DM) and impaired glucose tolerance (IGT) are not uncommonly associated with hypertension. Fasting blood glucose level is still recognized as an indicator of DM. We studied 99 consecutive patients who were not known to be diabetic patients and with no cardiac history, who were attending our Hypertension Clinic for investigation and management of uncontrolled blood pressure (BP). Oral glucose tolerance test (GTT) was carried out and area under the curve for the GTT (AUC-glucose) was calculated. All patients underwent 24-h ambulatory BP monitoring. The GTT was abnormal in 58 patients (58%), indicating IGT in 18, impaired fasting glucose in 16, and DM in 24. The fasting and 120-min glucose level and AUC-glucose in patients with DM on GTT was higher ( P < .0001) than in those with IGT/IFG and in the latter was higher than those with normal GTT. Multiple regression analysis showed that abnormal GTT was independent of the following: level of clinic or ambulatory BP; presence or absence of nocturnal BP dip; cholesterol, sodium, and potassium levels; smoking history; alcohol intake; prior treatment for hypertension; and ethnicity. These results were also independent of antihypertensive medications taken. No significant difference was found in glucose level during GTT, AUC-glucose, or age among the groups of patients receiving diuretics only, those receiving diuretics and β-blockers, and those not receiving any of these agents. The prevalence of glucose abnormalities in hypertensive patients attending a hospital hypertension clinic is sufficiently high to warrant screening for DM and IGT, and fasting glucose levels are not accurate enough for this purpose. All patients attending such a clinic should undergo a GTT.
doi_str_mv 10.1016/j.amjhyper.2004.01.011
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71977752</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0895706104000378</els_id><sourcerecordid>2712500011</sourcerecordid><originalsourceid>FETCH-LOGICAL-c508t-e28e215c119470869244411b8070000f0652b0eedaf9f6479c5b77ef7bd258b63</originalsourceid><addsrcrecordid>eNqFkd1u1DAQhSMEokvhFSpLCO6yeJLYju-gLaVIBaoKJMSN5TiTrUPWDnZStTw9Drv8iBukkSx5vhmdOSfLjoCugQJ_0a_1tr--GzGsC0qrNYVUcC9bQS1kDpKy-9mK1pLlgnI4yB7F2NMEcg4PswNgIAQDucr6y4A3ekBnkPiOzC6g8Rtnv2NLdON82OqBbIbZ-Ihk8gMGvaDWkVFPFt0UiZ4mdK11G6LJtY-jndLIT2npP1rviBmss-Zx9qDTQ8Qn-_cw-3T2-uPJeX7x4c3bk1cXuWG0nnIsaiyAGQBZCVpzWVRVBdDUVKQDaEc5KxqK2OpOdrwS0rBGCOxE0xasbnh5mD3f7R2D_zZjnNTWRoPDoB36OSoBUqTriwQ-_Qfs_Rxc0qaAFpxVkpdloviOMsHHGLBTY7BbHe4SpJYsVK9-ZaGWLBSFVJAGj_br52aL7Z-xvfkJeLYHdDR66BZrbfyLq0tWUZG4fMfZOOHt774OXxUXpWDq_PMXdXX6_vTdZXWljhP_csdjcvnGJlnR2CXh1qZ0J9V6-z_tPwBPZbsA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1026549633</pqid></control><display><type>article</type><title>Prevalence of unrecognized abnormal glucose tolerance in patients attending a hospital hypertension clinic</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><creator>Salmasi, Abdul-Majeed ; Alimo, Audrey ; Dancy, Mark</creator><creatorcontrib>Salmasi, Abdul-Majeed ; Alimo, Audrey ; Dancy, Mark</creatorcontrib><description>Diabetes mellitus (DM) and impaired glucose tolerance (IGT) are not uncommonly associated with hypertension. Fasting blood glucose level is still recognized as an indicator of DM. We studied 99 consecutive patients who were not known to be diabetic patients and with no cardiac history, who were attending our Hypertension Clinic for investigation and management of uncontrolled blood pressure (BP). Oral glucose tolerance test (GTT) was carried out and area under the curve for the GTT (AUC-glucose) was calculated. All patients underwent 24-h ambulatory BP monitoring. The GTT was abnormal in 58 patients (58%), indicating IGT in 18, impaired fasting glucose in 16, and DM in 24. The fasting and 120-min glucose level and AUC-glucose in patients with DM on GTT was higher ( P &lt; .0001) than in those with IGT/IFG and in the latter was higher than those with normal GTT. Multiple regression analysis showed that abnormal GTT was independent of the following: level of clinic or ambulatory BP; presence or absence of nocturnal BP dip; cholesterol, sodium, and potassium levels; smoking history; alcohol intake; prior treatment for hypertension; and ethnicity. These results were also independent of antihypertensive medications taken. No significant difference was found in glucose level during GTT, AUC-glucose, or age among the groups of patients receiving diuretics only, those receiving diuretics and β-blockers, and those not receiving any of these agents. The prevalence of glucose abnormalities in hypertensive patients attending a hospital hypertension clinic is sufficiently high to warrant screening for DM and IGT, and fasting glucose levels are not accurate enough for this purpose. All patients attending such a clinic should undergo a GTT.</description><identifier>ISSN: 0895-7061</identifier><identifier>EISSN: 1879-1905</identifier><identifier>EISSN: 1941-7225</identifier><identifier>DOI: 10.1016/j.amjhyper.2004.01.011</identifier><identifier>PMID: 15177519</identifier><identifier>CODEN: AJHYE6</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Adrenergic beta-Antagonists - therapeutic use ; Adult ; Aged ; Aged, 80 and over ; Arterial hypertension. Arterial hypotension ; Biological and medical sciences ; Biomarkers - blood ; Blood and lymphatic vessels ; Blood Glucose - drug effects ; Blood Glucose - metabolism ; Blood Pressure Monitoring, Ambulatory ; Cardiology. Vascular system ; diabetes mellitus ; Diabetes Mellitus - drug therapy ; Diabetes Mellitus - epidemiology ; Diabetes Mellitus - metabolism ; Female ; Glucose tolerance ; Glucose Tolerance Test ; Humans ; hypertension ; Hypertension - drug therapy ; Hypertension - epidemiology ; Hypertension - metabolism ; impaired fasting glucose ; impaired glucose tolerance ; Male ; Medical sciences ; Middle Aged ; Outpatient Clinics, Hospital ; Prevalence ; Statistics as Topic ; Treatment Outcome ; Triglycerides - metabolism ; United Kingdom - epidemiology</subject><ispartof>American journal of hypertension, 2004-06, Vol.17 (6), p.483-488</ispartof><rights>2004 American Journal of Hypertension, Ltd.</rights><rights>2004 INIST-CNRS</rights><rights>Copyright Nature Publishing Group Jun 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c508t-e28e215c119470869244411b8070000f0652b0eedaf9f6479c5b77ef7bd258b63</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15835407$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15177519$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Salmasi, Abdul-Majeed</creatorcontrib><creatorcontrib>Alimo, Audrey</creatorcontrib><creatorcontrib>Dancy, Mark</creatorcontrib><title>Prevalence of unrecognized abnormal glucose tolerance in patients attending a hospital hypertension clinic</title><title>American journal of hypertension</title><addtitle>AJH</addtitle><description>Diabetes mellitus (DM) and impaired glucose tolerance (IGT) are not uncommonly associated with hypertension. Fasting blood glucose level is still recognized as an indicator of DM. We studied 99 consecutive patients who were not known to be diabetic patients and with no cardiac history, who were attending our Hypertension Clinic for investigation and management of uncontrolled blood pressure (BP). Oral glucose tolerance test (GTT) was carried out and area under the curve for the GTT (AUC-glucose) was calculated. All patients underwent 24-h ambulatory BP monitoring. The GTT was abnormal in 58 patients (58%), indicating IGT in 18, impaired fasting glucose in 16, and DM in 24. The fasting and 120-min glucose level and AUC-glucose in patients with DM on GTT was higher ( P &lt; .0001) than in those with IGT/IFG and in the latter was higher than those with normal GTT. Multiple regression analysis showed that abnormal GTT was independent of the following: level of clinic or ambulatory BP; presence or absence of nocturnal BP dip; cholesterol, sodium, and potassium levels; smoking history; alcohol intake; prior treatment for hypertension; and ethnicity. These results were also independent of antihypertensive medications taken. No significant difference was found in glucose level during GTT, AUC-glucose, or age among the groups of patients receiving diuretics only, those receiving diuretics and β-blockers, and those not receiving any of these agents. The prevalence of glucose abnormalities in hypertensive patients attending a hospital hypertension clinic is sufficiently high to warrant screening for DM and IGT, and fasting glucose levels are not accurate enough for this purpose. All patients attending such a clinic should undergo a GTT.</description><subject>Adrenergic beta-Antagonists - therapeutic use</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Arterial hypertension. Arterial hypotension</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Blood and lymphatic vessels</subject><subject>Blood Glucose - drug effects</subject><subject>Blood Glucose - metabolism</subject><subject>Blood Pressure Monitoring, Ambulatory</subject><subject>Cardiology. Vascular system</subject><subject>diabetes mellitus</subject><subject>Diabetes Mellitus - drug therapy</subject><subject>Diabetes Mellitus - epidemiology</subject><subject>Diabetes Mellitus - metabolism</subject><subject>Female</subject><subject>Glucose tolerance</subject><subject>Glucose Tolerance Test</subject><subject>Humans</subject><subject>hypertension</subject><subject>Hypertension - drug therapy</subject><subject>Hypertension - epidemiology</subject><subject>Hypertension - metabolism</subject><subject>impaired fasting glucose</subject><subject>impaired glucose tolerance</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Outpatient Clinics, Hospital</subject><subject>Prevalence</subject><subject>Statistics as Topic</subject><subject>Treatment Outcome</subject><subject>Triglycerides - metabolism</subject><subject>United Kingdom - epidemiology</subject><issn>0895-7061</issn><issn>1879-1905</issn><issn>1941-7225</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkd1u1DAQhSMEokvhFSpLCO6yeJLYju-gLaVIBaoKJMSN5TiTrUPWDnZStTw9Drv8iBukkSx5vhmdOSfLjoCugQJ_0a_1tr--GzGsC0qrNYVUcC9bQS1kDpKy-9mK1pLlgnI4yB7F2NMEcg4PswNgIAQDucr6y4A3ekBnkPiOzC6g8Rtnv2NLdON82OqBbIbZ-Ihk8gMGvaDWkVFPFt0UiZ4mdK11G6LJtY-jndLIT2npP1rviBmss-Zx9qDTQ8Qn-_cw-3T2-uPJeX7x4c3bk1cXuWG0nnIsaiyAGQBZCVpzWVRVBdDUVKQDaEc5KxqK2OpOdrwS0rBGCOxE0xasbnh5mD3f7R2D_zZjnNTWRoPDoB36OSoBUqTriwQ-_Qfs_Rxc0qaAFpxVkpdloviOMsHHGLBTY7BbHe4SpJYsVK9-ZaGWLBSFVJAGj_br52aL7Z-xvfkJeLYHdDR66BZrbfyLq0tWUZG4fMfZOOHt774OXxUXpWDq_PMXdXX6_vTdZXWljhP_csdjcvnGJlnR2CXh1qZ0J9V6-z_tPwBPZbsA</recordid><startdate>20040601</startdate><enddate>20040601</enddate><creator>Salmasi, Abdul-Majeed</creator><creator>Alimo, Audrey</creator><creator>Dancy, Mark</creator><general>Elsevier Inc</general><general>Oxford University Press</general><general>Elsevier Science</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20040601</creationdate><title>Prevalence of unrecognized abnormal glucose tolerance in patients attending a hospital hypertension clinic</title><author>Salmasi, Abdul-Majeed ; Alimo, Audrey ; Dancy, Mark</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c508t-e28e215c119470869244411b8070000f0652b0eedaf9f6479c5b77ef7bd258b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adrenergic beta-Antagonists - therapeutic use</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Arterial hypertension. Arterial hypotension</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Blood and lymphatic vessels</topic><topic>Blood Glucose - drug effects</topic><topic>Blood Glucose - metabolism</topic><topic>Blood Pressure Monitoring, Ambulatory</topic><topic>Cardiology. Vascular system</topic><topic>diabetes mellitus</topic><topic>Diabetes Mellitus - drug therapy</topic><topic>Diabetes Mellitus - epidemiology</topic><topic>Diabetes Mellitus - metabolism</topic><topic>Female</topic><topic>Glucose tolerance</topic><topic>Glucose Tolerance Test</topic><topic>Humans</topic><topic>hypertension</topic><topic>Hypertension - drug therapy</topic><topic>Hypertension - epidemiology</topic><topic>Hypertension - metabolism</topic><topic>impaired fasting glucose</topic><topic>impaired glucose tolerance</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Outpatient Clinics, Hospital</topic><topic>Prevalence</topic><topic>Statistics as Topic</topic><topic>Treatment Outcome</topic><topic>Triglycerides - metabolism</topic><topic>United Kingdom - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Salmasi, Abdul-Majeed</creatorcontrib><creatorcontrib>Alimo, Audrey</creatorcontrib><creatorcontrib>Dancy, Mark</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of hypertension</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Salmasi, Abdul-Majeed</au><au>Alimo, Audrey</au><au>Dancy, Mark</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence of unrecognized abnormal glucose tolerance in patients attending a hospital hypertension clinic</atitle><jtitle>American journal of hypertension</jtitle><addtitle>AJH</addtitle><date>2004-06-01</date><risdate>2004</risdate><volume>17</volume><issue>6</issue><spage>483</spage><epage>488</epage><pages>483-488</pages><issn>0895-7061</issn><eissn>1879-1905</eissn><eissn>1941-7225</eissn><coden>AJHYE6</coden><abstract>Diabetes mellitus (DM) and impaired glucose tolerance (IGT) are not uncommonly associated with hypertension. Fasting blood glucose level is still recognized as an indicator of DM. We studied 99 consecutive patients who were not known to be diabetic patients and with no cardiac history, who were attending our Hypertension Clinic for investigation and management of uncontrolled blood pressure (BP). Oral glucose tolerance test (GTT) was carried out and area under the curve for the GTT (AUC-glucose) was calculated. All patients underwent 24-h ambulatory BP monitoring. The GTT was abnormal in 58 patients (58%), indicating IGT in 18, impaired fasting glucose in 16, and DM in 24. The fasting and 120-min glucose level and AUC-glucose in patients with DM on GTT was higher ( P &lt; .0001) than in those with IGT/IFG and in the latter was higher than those with normal GTT. Multiple regression analysis showed that abnormal GTT was independent of the following: level of clinic or ambulatory BP; presence or absence of nocturnal BP dip; cholesterol, sodium, and potassium levels; smoking history; alcohol intake; prior treatment for hypertension; and ethnicity. These results were also independent of antihypertensive medications taken. No significant difference was found in glucose level during GTT, AUC-glucose, or age among the groups of patients receiving diuretics only, those receiving diuretics and β-blockers, and those not receiving any of these agents. The prevalence of glucose abnormalities in hypertensive patients attending a hospital hypertension clinic is sufficiently high to warrant screening for DM and IGT, and fasting glucose levels are not accurate enough for this purpose. All patients attending such a clinic should undergo a GTT.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>15177519</pmid><doi>10.1016/j.amjhyper.2004.01.011</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0895-7061
ispartof American journal of hypertension, 2004-06, Vol.17 (6), p.483-488
issn 0895-7061
1879-1905
1941-7225
language eng
recordid cdi_proquest_miscellaneous_71977752
source Oxford University Press Journals All Titles (1996-Current); MEDLINE
subjects Adrenergic beta-Antagonists - therapeutic use
Adult
Aged
Aged, 80 and over
Arterial hypertension. Arterial hypotension
Biological and medical sciences
Biomarkers - blood
Blood and lymphatic vessels
Blood Glucose - drug effects
Blood Glucose - metabolism
Blood Pressure Monitoring, Ambulatory
Cardiology. Vascular system
diabetes mellitus
Diabetes Mellitus - drug therapy
Diabetes Mellitus - epidemiology
Diabetes Mellitus - metabolism
Female
Glucose tolerance
Glucose Tolerance Test
Humans
hypertension
Hypertension - drug therapy
Hypertension - epidemiology
Hypertension - metabolism
impaired fasting glucose
impaired glucose tolerance
Male
Medical sciences
Middle Aged
Outpatient Clinics, Hospital
Prevalence
Statistics as Topic
Treatment Outcome
Triglycerides - metabolism
United Kingdom - epidemiology
title Prevalence of unrecognized abnormal glucose tolerance in patients attending a hospital hypertension clinic
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T11%3A09%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20of%20unrecognized%20abnormal%20glucose%20tolerance%20in%20patients%20attending%20a%20hospital%20hypertension%20clinic&rft.jtitle=American%20journal%20of%20hypertension&rft.au=Salmasi,%20Abdul-Majeed&rft.date=2004-06-01&rft.volume=17&rft.issue=6&rft.spage=483&rft.epage=488&rft.pages=483-488&rft.issn=0895-7061&rft.eissn=1879-1905&rft.coden=AJHYE6&rft_id=info:doi/10.1016/j.amjhyper.2004.01.011&rft_dat=%3Cproquest_cross%3E2712500011%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1026549633&rft_id=info:pmid/15177519&rft_els_id=S0895706104000378&rfr_iscdi=true